Ｔｅｉｃｏｐｌａｎｉｎ投与が有効であった再燃性ＭＲＳＡ骨髄炎の１例

• 継田 雅美

  新潟市民病院薬剤部

• 吉川 博子

  新潟市民病院内科

書誌事項

タイトル別名

• A case of teicoplanin medication in reinfected methicillin-resistant Staphylococcus aureus osteomyelitis.

抄録

A 59-year-old woman with methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis treated using teicoplanin (TEIC) had moderate chronic renal failure, so she was treated carefully with therapeutic drug monitoring (TDM) of TEIC. At first, she was treated with vancomycin (VCM) by intravenous infusion and VCM bead replacement therapy. Short-term remission was achieved, but only 2 months of treatment for renal failure was exacerbated, so the interruption of treatment led her osteomyelitis to recur. TEIC has 2 advantages over other anti-MRSA drugslittle influence on the kidneys, and good treatment of bone-so we chose TEIC for this patient, using TDM to set the adequate dose and interval. TEIC can be used in long-term medication without reducing kidney function and can be used safely and effectively with TDM, meaning TEIC is a possible alternative in treating MRSA osteomyelitis.

収録刊行物

• 日本化学療法学会雑誌

  日本化学療法学会雑誌 50 (3), 190-192, 2002

  公益社団法人 日本化学療法学会

キーワード

• MRSA
• teicoplanin
• TDM
• osteomyelitis

詳細情報

• CRID: 1390282681262485632
• NII論文ID: 130004298107
• NII論文ID: 10008327374
• NII書誌ID: AN10472127
• DOI: 10.11250/chemotherapy1995.50.190
• ISSN: 18845886
• ISSN: 13407007
• Web Site: https://search.jamas.or.jp/link/ui/2002173322
• 本文言語コード: ja
• データソース種別:
  • JaLC
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可